Trisura Group Reports Second Quarter 2025 Results: 21% Growth in BVPS and Significant Progress in Surety Expansion

TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Trisura Group Ltd. ("Trisura" or "Trisura Group") (TSX:TSU), a leading specialty insurance provider, today announced financial results for the second quarter of 2025.

David Clare, President and CEO of Trisura, stated,

"In Q2, we achieved a strong Operating ROE of 17.8% with Operating net income of $33.3 million or $0.69 per share. We continued to benefit from our Specialty focus, disciplined underwriting and growing investment income. Profitable underwriting resulted in a quarterly Combined ratio of 85.6%. We observed the most significant growth in Primary Lines, with a 35.1% increase across segments which carry a significantly higher underwriting margin profile and contribute most meaningfully to profitability.

We continue to make progress in our Surety platform, with 60.7% growth in quarterly premiums as we gain momentum in the US and expanded our Canadian presence. In the quarter, we further capitalized our US Surety balance sheet, enhancing its capacity to underwrite, while maintaining a conservative 13.8% Debt-to-capital ratio, demonstrating a strong posture to continue pursuing accretive growth.

Consistent growth in book value, reaching a new record $843 million at Q2, has been achieved through strong underwriting and investment returns."  Highlights

Operating ROE(1) of 17.8% was strong, reflecting profitability from core operations (ROE(1) of 15.6% in the quarter).

BVPS(2) of $17.63 increased 21.1% over Q2 2024 demonstrating consistent expansion in book value, with EPS of $0.76 in the quarter and a strong financial position.

Operating net income(3) was $33.3 million in the quarter, which increased over the prior year as a result of growth in Underwriting income(3) and Net investment income. Net income of $37.1 million was greater than Operating net income primarily as a result of higher Net gains on the investment portfolio.

Operating EPS(1) of $0.69 in the quarter increased by 6.2% demonstrating the strength of core operations(4) through continued growth and profitability.

Combined ratio(1) for the quarter was 85.6%, reflecting a strong underwriting performance across the portfolio.

GPW(2) growth of 8.9% in Q2 2025, excluding Exited lines from 2025 and 2024. This was led by growth of 35.1% in our Primary lines(5), which carry a significantly higher underwriting margin profile and contribute most meaningfully to profitability.

Net insurance revenue(3) growth of 18.1% in Q2 2025 was led by momentum in Primary lines, as well as growth in US Programs.

 

Q2 2025

 

Q2 2024

 

Variance

 

YTD 2025

 

YTD 2024

 

Variance

 

GPW

900,376

 

 

956,117

 

 

(5.8

%)

 

1,612,047

 

 

1,679,247

 

 

(4.0

%)

 

Net insurance revenue

195,785

 

 

165,831

 

 

18.1

%

 

368,495

 

 

318,885

 

 

15.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Underwriting income

28,183

 

 

25,410

 

 

10.9

%

 

58,039

 

 

54,769

 

 

6.0

%

 

Net investment income

18,864

 

 

16,902

 

 

11.6

%

 

37,061

 

 

33,655

 

 

10.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating net income

33,258

 

 

31,253

 

 

6.4

%

 

67,428

 

 

64,442

 

 

4.6

%

 

Net income

37,129

 

 

27,141

 

 

36.8

%

 

66,119

 

 

63,574

 

 

4.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss ratio(1)

33.2

%

 

33.4

%

 

(0.2

pts)

 

32.4

%

 

32.5

%

 

(0.1

pts)

 

Expense ratio(1)

52.4

%

 

51.3

%

 

1.1

pts

 

51.9

%

 

50.3

%

 

1.6

pts

 

Combined ratio

85.6

%

 

84.7

%

 

0.9

pts

 

84.3

%

 

82.8

%

 

1.5

pts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OEPS - diluted - in dollars

0.69

 

 

0.65

 

 

6.2

%

 

1.39

 

 

1.33

 

 

4.5

%

 

EPS - diluted - in dollars

0.76

 

 

0.56

 

 

35.7

%

 

1.36

 

 

1.31

 

 

3.8

%

 

BVPS - in dollars

17.63

 

 

14.56

 

 

21.1

%

 

17.63

 

 

14.56

 

 

21.1

%

 

Debt-to-capital ratio(2)

13.8

%

 

12.4

%

 

1.4

pts

 

13.8

%

 

12.4

%

 

1.4

pts 

 

Operating ROE

17.8

%

 

19.6

%

 

(1.8

pts)

 

17.8

%

 

19.6

%

 

(1.8

pts)

 

ROE

15.6

%

 

14.4

%

 

1.2

pts

 

15.6

%

 

14.4

%

 

1.2

pts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated Performance

Net insurance revenue of $195.8 million, increased by 18.1% compared to Q2 2024, reflecting growth in the business, and in particular, growth in our Primary Lines.

Underwriting income of $28.2 million, increased by 10.9% compared to Q2 2024 due to growth in the business, partially offset by a slightly higher Combined ratio.

The consolidated Combined ratio of 85.6% was higher for the quarter compared to prior year as a result of a higher Expense ratio.

Net investment income rose 11.6% in the quarter compared to Q2 2024 as the investment portfolio continues to grow.

Net Income and Operating Net Income

Operating net income of $33.3 million, increased 6.4% compared to Q2 2024 as a result of growth in insurance operations and growth in Net investment income.

Net income of $37.1 million, increased by 36.8% compared to Q2 2024, as a result of Net gains on the investment portfolio, along with growth in Underwriting income and Net investment income.

Operating ROE of 17.8% (ROE 15.6%) was slightly lower than Q2 2024, as strong profitability from core operations continued, but was partially offset by disproportionately higher Shareholders' equity as a result of unrealized gains on the investment portfolio.

Capital

The Company and its regulated specialty insurance subsidiaries are ...